Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 7/20 | 0.58 |
| ▸ | PGK2 | P07205 | 7/20 | 0.58 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 2/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1542035 | 0.97 | PGK1 (0.61) | PGK1PGK2PTPN1LMNAFDPS | |
| Hydrochloric Acid SCHEMBL18641130 | 0.93 | PGK1 (0.58) | PGK1PGK2PTPN1LMNAFDPS | |
| SCHEMBL1235045 | 0.82 | PGK1 (0.69) | PGK1PGK2PTPN1LMNAFDPS | |
| SCHEMBL1541142 | 0.78 | PGK1 (0.55) | PGK1PGK2PTPN1LMNAFDPS | |
| SCHEMBL12762079 | 0.76 | PGK1 (0.61) | PGK1PGK2PTPN1LMNAFDPS | |
| SCHEMBL12762109 | 0.76 | PGK1 (0.61) | PGK1PGK2PTPN1LMNAFDPS | |
| SCHEMBL186903 | 0.76 | PGK1 (0.45) | PGK1PGK2PTPN1 | |
| SCHEMBL442637 | 0.75 | PGK1 (0.52) | PGK1PGK2PTPN1LMNA | |
| SCHEMBL3803058 | 0.75 | PGK1 (0.52) | PGK1PGK2PTPN1LMNA | |
| SCHEMBL12762061 | 0.73 | PGK1 (0.58) | PGK1PGK2PTPN1LMNAFDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7145004-B2 | Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates and perfluoroalkylphosphonates | MERCK PATENT GESELLSCHAFT (DE) | 2006-12-05 | — | — | US | disclosed |
| US-20050222411-A1 | Method for the production of monohydro-perfluoroalkanes, bis (perfluoroalkyl) phosphinates and perfluoroalkylphosphonates | MERCK PATENT GMBH (DE) | 2005-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050222411-A1 | Method for the production of monohydro-perfluoroalkanes, bis (perfluoroalkyl) phosphinates and perfluoroalkylphosphonates | PFAS, PFKFB2, PHOSPHO1 | PGK1 670/4885PGK2 664/4885PTPN1 956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.